Physician profile
Maria E Lopez
NPI 1679870695
$474.38
in general payments reported to CMS, 2019-2025
10 companies · $77.93 in 2025
The $77.93 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.58 · 2022: $56.40 · 2023: $145 · 2024: $123 · 2025: $77.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $91.62 | 2021-2025 | Wegovy |
| Glaxosmithkline, LLC. | $89.49 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Abbott Laboratories | $63.01 | 2024 | Mitraclip, Freestyle Libre 3 |
| Abbvie INC. | $51.08 | 2022-2023 | |
| Exact Sciences Corporation | $48.04 | 2023-2024 | Cologuard Collection Kit |
| Dexcom, INC. | $35.06 | 2022-2024 | Dexcom G6 Transmitter |
| Viiv Healthcare Company | $25.79 | 2023 | Cabenuva |
| Sanofi Pasteur INC. | $23.91 | 2021 | |
| Hologic Sales and Service, LLC | $23.29 | 2023 | Thinprep 2000 Processor, Aptima |
| Merck Sharp & Dohme LLC | $23.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.